GRDX
NASD GridAI Technologies Corp.$4.97 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.97, $0.07 below the day’s high of $5.04
- YTD change
- +6.65%
- vs 20-day SMA
- +40.21%
- vs 200-day SMA
- +44.64%
Price ranges
Price & Performance
+2.94 (+144.83%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 28.3% away from all-time highs of $6.93
- GRDX is up 7% since the beginning of the year
- GRDX is up 100% over the past 12 months
- GRDX is up 67% over the past 1 month
- 1% of all GRDX investors are betting against GRDX
GRDX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +100.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.14
- Last 5 days
- +44.48%
- vs 8-day SMA
- +27.80%
No alerts for GRDX in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.